Edgewise rated as a new Hold at Stifel on a balanced risk-reward setup
Shares of Edgewise Therapeutics (NASDAQ:EWTX) traded flat on Wednesday after Stifel launched its coverage with a Hold recommendation, indicating a balanced risk-reward profile for the muscle drug ...
Stifel maintains Procter & Gamble stock hold with $161 target
Stifel analysts maintained a Hold rating on Procter & Gamble stock (NYSE:PG) with a steady price target of $161.00. The ...
Cytokinetics initiated with a Buy at Stifel
Stifel initiated coverage of Cytokinetics (CYTK) with a Buy rating and $80 price target Cytokinetics “is an out-of-favor stock” following the ...